Characterization of Δ9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1998-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0091-3057(97)00583-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.

  1997cited by this paper
• Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.

  1997cited by this paper
• SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.

  1997cited by this paper
• N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.

  1996cited by this paper
• Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.

  1996cited by this paper
• In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

  1996cited by this paper
• The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.

  1996cited by this paper
• Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

  1996cited by this paper
• Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities.

  1996cited by this paper
• Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid‐mediated blockade of long‐term potentiation in the rat hippocampal slice

  1995cited by this paper
• Pharmacological and behavioral evaluation of alkylated anandamide analogs.

  1995cited by this paper
• Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.

  1995cited by this paper
• Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.

  1995cited by this paper
• Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.

  1995cited by this paper
• Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats.

  1995cited by this paper
• Anandamides: tolerance and cross-tolerance toΔ9-tetrahydrocannabinol

  1995cited by this paper
• Antisense oligodeoxynucleotides to the κ-1 receptor block the antinociceptive effects of Δ9-THC in the spinal cord

  1995cited by this paper
• Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.

  1995cited by this paper
• The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor.

  1994cited by this paper
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons

  1994cited by this paper
• Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH).

  1994cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

  1994cited by this paper
• Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.

  1994cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.

  1993cited by this paper
• Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

  1993cited by this paper
• Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

  1993cited by this paper
• Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.

  1992cited by this paper
• Time-dependent changes in the activity of opioid systems in the spinal cord of monoarthritic rats--a release and in situ hybridization study.

  1992cited by this paper
• Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism.

  1991cited by this paper
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA

  1990cited by this paper
• Formation of [Leu5]Enkephalin from Dynorphin A(1–8) by Rat Central Nervous Tissue In Vitro

  1990cited by this paper
• Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord.

  1989cited by this paper
• Morphine self-administration in the rat during adjuvant-induced arthritis.

  1989cited by this paper
• Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.

  1988cited by this paper
• Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding

  1988cited by this paper
• Determination and characterization of a cannabinoid receptor in rat brain.

  1988cited by this paper
• Assessment of plasma leukotriene and prostaglandin levels during adjuvant arthritis and kaolin-induced paw oedema in rats.

  1988cited by this paper
• Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism

  1988cited by this paper
• Structure-activity relationships of the cannabinoids.

  1987cited by this paper
• Opioid Peptide Processing and Receptor Selectivity

  1986cited by this paper
• Manual of Pharmacologic Calculations: With Computer Programs

  1984cited by this paper
• Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat.

  1982cited by this paper
• Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.

  1981cited by this paper
• Adjuvant‐induced arthritis in rats: A possible animal model of chronic pain

  1981cited by this paper
• Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC).

  1973cited by this paper
• A method for measurement of analgesic activity on inflamed tissue.

  1957cited by this paper

• Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility

  2025cites this paper
• Endocannabinoid System Receptors at the Hip and Stifle Joints of Middle-Aged Dogs: A Novel Target for the Therapeutic Use of Cannabis sativa Extract in Canine Arthropathies

  2023cites this paper
• Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions

  2023cites this paper
• Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.

  2023cites this paper
• Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells

  2022cites this paper
• High-CBD Cannabis Vapor Attenuates Opioid Reward and Partially Modulates Nociception in Female Rats

  2022cites this paper
• Contribution of P2X4 receptor in pain associated with rheumatoid arthritis: a review

  2021cites this paper
• Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application.

  2021cites this paper
• Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand

  2021cites this paper
• Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2‐arachidonoyl‐glycerol and its congeners in human myeloid leukocytes

  2020cites this paper
• Cannabinoids in the treatment of rheumatic diseases: Pros and cons.

  2019cites this paper
• Core Outcome Measures in Preclinical Assessment of Candidate Analgesics

  2019cites this paper
• Machine-learned analysis of the association of next-generation sequencing based genotypes with persistent pain after breast cancer surgery.

  2019cites this paper
• Human leukocytes differentially express endocannabinoid‐glycerol lipases and hydrolyze 2‐arachidonoyl‐glycerol and its metabolites from the 15‐lipoxygenase and cyclooxygenase pathways

  2019influential citation
• Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55

  2019cites this paper
• Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

  2018cites this paper
• Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

  2018cites this paper
• Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

  2018cites this paper
• Cannabidiol-Δ-tetrahydrocannabinol interactions on acute pain and locomotor activity

  2017cites this paper
• Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study

  2017cites this paper
• Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity.

  2017cites this paper
• Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats

  2017cites this paper
• Assessment of the role of CB receptors in cannabinoid 1 anticonvulsant effects

  2016cites this paper
• A data science approach to candidate gene selection of pain regarded as a process of learning and neural plasticity

  2016cites this paper
• Marijuana and Cannabinoids for Pain

  2016cites this paper
• The endocannabinoid system and its therapeutic implications in rheumatoid arthritis.

  2015cites this paper
• Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

  2015cites this paper
• of Medicinal Marijuana , Cannabinoids , and Therapeutic Implications in Medicine and Headache : What a Long Strange Trip It ’ s

  2015cites this paper
• Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.

  2014cites this paper
• Rôle et implication du système cannabinoïde dans la modulation périphérique de la douleur inflammatoire et neuropathique

  2014cites this paper
• Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.

  2014cites this paper
• Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate

  2013cites this paper
• TRP Receptors in Arthritis, Gaining Knowledge for Translation from Experimental Models

  2013cites this paper
• Dynamic changes to the endocannabinoid system in models of chronic pain

  2012cites this paper
• A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors

  2012cites this paper
• Interactions between &Dgr;9-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys

  2012cites this paper
• N-(4-Methoxy-2-nitrophenyl)hexadecanamide, a palmitoylethanolamide analogue, reduces formalin-induced nociception.

  2012cites this paper
• High-performance liquid chromatography-tandem mass spectrometry assay of fatty acid amide hydrolase (FAAH) in blood: FAAH inhibition as clinical biomarker.

  2012cites this paper
• Philosophy at Virginia Commonwealth University.

  2011cites this paper
• Peripheral analgesia: Hitting pain where it hurts.

  2011cites this paper
• Targeting the endocannabinoid system to reduce nociception

  2011cites this paper
• Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp.

  2010cites this paper
• Cannabinoids and Reproduction: A Lasting and Intriguing History

  2010cites this paper
• Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.

  2010cites this paper
• Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity

  2010cites this paper
• Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain.

  2010cites this paper
• The endocannabinoid system and pain.

  2009cites this paper
• Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.

  2009cites this paper
• Glycine transporter 1 associates with cholesterol-rich membrane raft microdomains.

  2009cites this paper
• Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.

  2009cites this paper
• Targeting the cannabinoid system to produce analgesia.

  2009cites this paper
• Stress-induced analgesia.

  2009cites this paper
• Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

  2009cites this paper
• Interaction of the cannabinoid and opioid systems in the modulation of nociception

  2009cites this paper
• Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis

  2008cites this paper
• Role of Cannabinoids in the Management of Neuropathic Pain

  2008cites this paper
• Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.

  2008cites this paper
• A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis

  2008cites this paper
• The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level

  2008cites this paper
• Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.

  2008cites this paper
• Marijuana: Pharmacology and Interaction with the Endocannabinoid System

  2007cites this paper
• The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L‐29) on pain behaviour in rodent models of neuropathy

  2007influential citation
• Synergy between Δ9-tetrahydrocannabinol and morphine in the arthritic rat

  2007influential citation
• Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers

  2007cites this paper
• Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.

  2007influential citation
• Actions of N-arachidonyl-glycine in a rat inflammatory pain model

  2007cites this paper
• The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.

  2007cites this paper
• The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes

  2007cites this paper
• ACTIONS OF THE ENDOCANNABINOID TRANSPORT INHIBITOR AM404 IN NEUROPATHIC AND INFLAMMATORY PAIN MODELS

  2007cites this paper
• Cannabinoids and pain.

  2007cites this paper
• Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid‐induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception

  2007influential citation
• Ultra-Low Dose Antagonist Effects on Cannabinoids and Opioids in Models of Pain: Is Less More?

  2007cites this paper
• Capítulo 34 – Canabinoides

  2007cites this paper
• The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor

  2007cites this paper
• Short communication Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB 1 receptors

  2007cites this paper
• Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cites this paper
• The Additive Antinociceptive Interaction Between WIN 55,212-2, a Cannabinoid Agonist, and Ketorolac

  2006cites this paper
• Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.

  2006cites this paper
• Neurons in a Rodent Model of Neuropathic Pain Effects of a Cannabinoid Agonist on Spinal Nociceptive

  2006cites this paper
• Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

  2006cites this paper
• Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.

  2006cites this paper
• The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids

  2006cites this paper
• Therapeutic potential of cannabinoid receptor agonists as analgesic agents

  2005influential citation
• The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

  2005cites this paper
• Ultra-low dose naltrexone enhances cannabinoid-induced antinociception

  2005cites this paper
• A cannabinoid agonist, WIN 55,212‐2, reduces neuropathic nociception induced by paclitaxel in rats

  2005cites this paper
• Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice.

  2005cites this paper
• Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.

  2005cites this paper
• Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.

  2005cites this paper
• Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

  2005cites this paper
• An approach to the management of the pruritus of cholestasis.

  2004cites this paper
• The endogenous cannabinoid system and its role in nociceptive behavior.

  2004influential citation
• Anandamide inhibits the DOI-induced head-twitch response in mice

  2004cites this paper
• The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.

  2004cites this paper
• Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor‐mediated phenotypic hypoalgesia

  2004cites this paper
• 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects

  2004cites this paper
• Pro-algesic versus analgesic actions of immune cells

  2003cites this paper
• The analgesic effect of oral delta‐9‐tetrahydrocannabinol (THC), morphine, and a THC‐morphine combination in healthy subjects under experimental pain conditions

  2003cites this paper
• Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.

  2003cites this paper